By Dermavir We are a Phase II therapeutic vaccine company with a lead product candidate for the treatment of HIV.
Although the HIV epidemic, as we know it toda...
By @SimonCocking
Describe the company – the elevator pitch ...
Genetic Immunity is a privately held clinical-stage biotechnology company focusing on the ...
Three Lakes Partners, a venture philanthropy committed to ending Idiopathic Pulmonary Fibrosis (IPF), named Irish based patientMpower, a provider of digital health solutions, among one of three overall winners of the $1,000,000 IPF Catalyst Challenge...
Abbott launched their new sensor technology for measuring glucose levels in Diabetes, about a year ago. The device was created for testing glucose levels in a l...
New revolutionary technology which screens and delivers an early diagnosis of dementia is to be rolled out across Ireland in Spring 2018. The technology, which ...
Great guest post by Michael Banks
Leading and selling is what all of us have to do at various times in our lives. And to succeed in both activities you have to be really good at building and maintaining good relationships with your people and your...
Innovation Zed, an Irish medtech company, today announced that it has commenced working with the NHS in South Yorkshire and Bassetlaw, England. The collaboratio...
Speaking at the RebelBio Demo Day in London, Emer O'Shea of Khonsu Therapeutics noted that although "short-term inflammation (acute) can oftentimes have a posit...
Novartis, in partnership with the NCBI, has announced the launch of a suite of vision assistance apps. The award-winning ViaOpta Navigator and ViaOpta Daily apps were developed to better assist those living with visual impairment. ViaOpta Navigator a...
